✦ LIBER ✦

Survival and prognosis of patients with astrocytoma with atypical or anaplastic features

✍ Scribed by Diana F Nelson; James S. Nelson; Deborah R. Davis; Chu Huai Chang; Thomas W. Griffins; Thomas F. Pajak

Publisher: Springer US
Year: 1985
Tongue: English
Weight: 281 KB
Volume: 3
Category: Article
ISSN: 0167-594X
DOI: 10.1007/bf02228884

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II trial of paclitaxel and topot

A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma

✍ J. Marc Pipas; Louise P. Meyer; C. Harker Rhodes; Laurence D. Cromwell; Carol E. 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 286 KB

Retinoblastoma protein expression and MI

Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma

✍ Mitsutoshi Nakamura; Noboru Konishi; Shigeru Tsunoda; Yoshio Hiasa; Toshihide Ts 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB

## Background: Regulatory coupling of cell proliferation and apoptosis is suggested by recent findings with regard to certain tumors, such as the finding of tumor resistance to anticancer therapy caused by inhibition of apoptosis. the processes leading to apoptosis appear to be regulated by a varie

Clinical and molecular features in patie

Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor

✍ Uwe Kordes; Stefan Gesk; Michael Christoph Frühwald; Norbert Graf; Ivo Leuschner 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

## Abstract The __SMARCB1__ gene status in 50 patients with atypical teratoid rhabdoid tumor and/or malignant rhabdoid tumor recruited to a German registry was prospectively analyzed with FISH and PCR. Altogether we found 40 __SMARCB1__ mutations in 28 patients. Two patients were positive for SMARC

A first feasibility study of temozolomid

A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme

✍ Tomokazu Aoki; Tomohiko Mizutani; Masatsune Ishikawa; Kazuhiko Sugiyama; Nobuo H 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 258 KB

Prognostic implication of clinical, radi

Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas

✍ Avelina Tortosa; Núria Viñolas; Salvador Villà; Eugènia Verger; Juan M. Gil; Mar 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB

## Abstract ## BACKGROUND The clinical evolution of anaplastic glioma (anaplastic astrocytoma, oligodendroglioma, and oligoastrocytoma) is variable. Previous studies merged patients with anaplastic glioma and the much more common glioblastoma multiforme. Therefore, the conclusions on prognostic fa

Does extent of surgery influence outcome

Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials

✍ Walter J. Curran; Charles B. Scott; John Horton; James S. Nelson; Alan S. Weinst 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 569 KB

103 patients with the diagnosis of AAF were identified from the RT/BCNU arms of 3 RTOG malignant glioma trials. Pre-treatment tumor size was < 5 cm for 48% and -> 5 cm for 52%, and tumor sites were frontal lobe in 55%, temporal in 25%, and parietal in 16%. Surgery consisted of biopsy for 30%, partia